239 related articles for article (PubMed ID: 37494818)
1. Tumor interstitial fluid analysis enables the study of microenvironment-cell interactions in cancers.
Apiz Saab JJ; Muir A
Curr Opin Biotechnol; 2023 Oct; 83():102970. PubMed ID: 37494818
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).
Gromov P; Gromova I
Methods Mol Biol; 2016; 1459():231-47. PubMed ID: 27665563
[TBL] [Abstract][Full Text] [Related]
3. Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of "tumor-phlegm microenvironment".
Sun DZ; Jiao JP; Ju DW; Ye M; Zhang X; Xu JY; Lu Y; He J; Wei PK; Yang MH
Chin J Integr Med; 2012 May; 18(5):350-8. PubMed ID: 22549391
[TBL] [Abstract][Full Text] [Related]
4. Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability.
Abbott KL; Ali A; Reinfeld BI; Deik A; Subudhi S; Landis MD; Hongo RA; Young KL; Kunchok T; Nabel CS; Crowder KD; Kent JR; Madariaga MLL; Jain RK; Beckermann KE; Lewis CA; Clish CB; Muir A; Rathmell WK; Rathmell J; Vander Heiden MG
Elife; 2024 May; 13():. PubMed ID: 38787918
[TBL] [Abstract][Full Text] [Related]
5. Interstitial Fluid in Gynecologic Tumors and Its Possible Application in the Clinical Practice.
Ura B; Di Lorenzo G; Romano F; Monasta L; Mirenda G; Scrimin F; Ricci G
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545144
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers Found in the Tumor Interstitial Fluid may Help Explain the Differential Behavior Among Keratinocyte Carcinomas.
Matas-Nadal C; Bech-Serra JJ; Gatius S; Gomez X; Ribes-Santolaria M; Guasch-Vallés M; Pedraza N; Casanova JM; de la Torre Gómez C; Garí E; Aguayo-Ortiz RS
Mol Cell Proteomics; 2023 Jun; 22(6):100547. PubMed ID: 37059366
[TBL] [Abstract][Full Text] [Related]
7. Tumor interstitial fluid: proteomic determination as a possible source of biomarkers.
Baronzio G; Parmar G; Baronzio M; Kiselevsky M
Cancer Genomics Proteomics; 2014; 11(5):225-37. PubMed ID: 25331795
[TBL] [Abstract][Full Text] [Related]
8. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
[TBL] [Abstract][Full Text] [Related]
9. Landscape of extracellular vesicles in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on metabolic reprogramming, horizontal transfer of neoplastic traits, and the emergence of therapeutic resistance.
Zhang DX; Vu LT; Ismail NN; Le MTN; Grimson A
Semin Cancer Biol; 2021 Sep; 74():24-44. PubMed ID: 33545339
[TBL] [Abstract][Full Text] [Related]
10. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
11. Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers.
Wei R; Liu S; Zhang S; Min L; Zhu S
Anal Cell Pathol (Amst); 2020; 2020():6283796. PubMed ID: 32377504
[TBL] [Abstract][Full Text] [Related]
12. Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis.
Baronzio G; Schwartz L; Kiselevsky M; Guais A; Sanders E; Milanesi G; Baronzio M; Freitas I
Anticancer Res; 2012 Feb; 32(2):405-14. PubMed ID: 22287726
[TBL] [Abstract][Full Text] [Related]
13. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.
Laha D; Grant R; Mishra P; Nilubol N
Front Immunol; 2021; 12():656908. PubMed ID: 33986746
[TBL] [Abstract][Full Text] [Related]
14. N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.
Terkelsen T; Haakensen VD; Saldova R; Gromov P; Hansen MK; Stöckmann H; Lingjaerde OC; Børresen-Dale AL; Papaleo E; Helland Å; Rudd PM; Gromova I
Mol Oncol; 2018 Jun; 12(6):972-990. PubMed ID: 29698574
[TBL] [Abstract][Full Text] [Related]
15. Structural Biology of the Tumor Microenvironment.
Freeman JW
Adv Exp Med Biol; 2021; 1350():91-100. PubMed ID: 34888845
[TBL] [Abstract][Full Text] [Related]
16. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
Allam A; Yakou M; Pang L; Ernst M; Huynh J
Front Immunol; 2021; 12():767939. PubMed ID: 34858425
[TBL] [Abstract][Full Text] [Related]
17. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
18. Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications.
Wagner M; Wiig H
Front Oncol; 2015; 5():115. PubMed ID: 26075182
[TBL] [Abstract][Full Text] [Related]
19. Insights into the tumor-stromal-immune cell metabolism cross talk in ovarian cancer.
Tang PW; Frisbie L; Hempel N; Coffman L
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C731-C749. PubMed ID: 37545409
[TBL] [Abstract][Full Text] [Related]
20. Visualizing Extracellular Vesicles and Their Function in 3D Tumor Microenvironment Models.
Ural EE; Toomajian V; Hoque Apu E; Veletic M; Balasingham I; Ashammakhi N; Kanada M; Contag CH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
